GlassScriptPhysician profile
Dana Potter
NPI 1568998987
$6,683.28
in general payments reported to CMS, 2019-2025
39 companies · $943 in 2025
The $943 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $377 · 2022: $795 · 2023: $1,130 · 2024: $3,438 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,184 · Long Term Medical Supply Or Device Loan: $1,970 · Education: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,183.64 |
| Long Term Medical Supply Or Device Loan | $1,969.97 |
| Education | $357.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,987.74 | 2022-2024 | Integra |
| Astellas Pharma US INC | $611.22 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $458.82 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $376.21 | 2023-2025 | Myfembree |
| Organon LLC | $357.79 | 2021-2025 | Nexplanon, Jada System |
| Pfizer INC. | $295.48 | 2022-2025 | |
| Exeltis, USA INC. | $261.39 | 2021-2024 | Slynd |
| Fisher Scientific Company L.L.C. | $257.89 | 2024 | Procalcitonin |
| Millicent US INC | $200.08 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Abbvie INC. | $177.97 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $175.14 | 2021-2024 | Exparel |
| Myovant Sciences INC. | $165.14 | 2021-2022 | |
| Gynesonics, INC. | $160.08 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $145.48 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $100.12 | 2022-2025 | Myosure Tissue Removal Device, Acessa Provu System, Coolseal Generator |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.